Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE. Den Boer ML, et al. Among authors: harms do. J Clin Oncol. 2003 Sep 1;21(17):3262-8. doi: 10.1200/JCO.2003.11.031. J Clin Oncol. 2003. PMID: 12947061
[In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
Janka-Schaub GE, Harms DO, den Boer ML, Veerman AJ, Pieters R. Janka-Schaub GE, et al. Among authors: harms do. Klin Padiatr. 1999 Jul-Aug;211(4):233-8. doi: 10.1055/s-2008-1043794. Klin Padiatr. 1999. PMID: 10472556 Clinical Trial. German.
[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
zur Stadt U, Harms DO, Schlüter S, Jorch N, Spaar HJ, Nürnberger W, Völpel S, Gutjahr P, Schrappe M, Janka G, Kabisch H. zur Stadt U, et al. Among authors: harms do. Klin Padiatr. 2000 Jul-Aug;212(4):169-73. doi: 10.1055/s-2000-9672. Klin Padiatr. 2000. PMID: 10994545 Clinical Trial. German.
231 results